Locations:
Abu Dhabi|Canada|Florida|London|Nevada|Ohio|
Gray gradientGray gradient
Cleveland Clinic icon
Consult QD logo
Search IconSearch

Neurosciences

19-ENT-922-depressionRhinitis-CQD-650×450
June 13, 2019/Neurosciences

Risk of Depression Is Twice as High in Patients With Nonallergic Rhinitis, Study Finds

Physicians caring for patients with rhinitis should be cognizant of association with depression

19-NEU-430-cafe-au-lait-650×450

Café-Au-Lait Macules and Macrocephaly in a 19-Month-Old: Diagnostic Considerations Beyond Neurofibromatosis

Case study underscores need to factor in a rare syndrome

19-NEU-517-3D-Printed-Aneurysm-650×450

3D-Printed Replica of Brain Aneurysm Helps Guide Surgical Repair

One of first reported uses of the technology for a cerebrovascular malformation

19-NEU-319-Caren-Treadmill-MS-650×450
June 4, 2019/Neurosciences/Research

Virtual Reality Platform’s Dynamic Approach to Physical Therapy Yields Benefits in MS

Preliminary study finds improved gait and balance vs. traditional PT

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Stationary bike
May 30, 2019/Neurosciences/Research

Can Exercise Alter Parkinson Disease Progression? NIH Award Launches First Long-Term Study to Find Out

Study to assess effects of 12 months of home-based cycling

Neurosurgeon

Benzel Symposium Launched AANS Meeting with Reflections on Spine Care — and an Eye to the Future

Neurosurgery luminaries share a generation’s worth of experience and wisdom

650×450-Distressed-Teen
May 10, 2019/Neurosciences

Higher Healthcare Costs Reported in Children with Co-Occurring Medical and Mental Health Conditions

Integrated care improves outcomes and reduces costs

19-NEU-321-excessive-sleepiness-650×450

Solriamfetol Demonstrates Safety, Efficacy for Wakefulness in 1-Year Extension Trial

New drug for adults with OSA or narcolepsy expected to launch soon

19-NEU-320-RNS-neurostimulation-650×450

Seizure Reductions with Responsive Neurostimulation Grow Over Time, Long-Term Study Shows

75% median reduction in seizures observed over 9 years of treatment

Immune system
May 7, 2019/Cancer

Degree of Immunosuppression Predicts Glioblastoma Prognosis, Temozolomide Studies Suggest

Experience to date highlights need for immunotherapy focus

BackPage 70 of 84Next

Advertisement

Ad